Grifols, S.A Total Non-Cash Items 2012-2024 | GRFS

Grifols, S.A total non-cash items from 2012 to 2024. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
Grifols, S.A Annual Total Non-Cash Items
(Millions of US $)
2024 $1,280
2023 $1,107
2022 $822
2021 $680
2020 $468
2019 $638
2018 $537
2017 $629
2016 $434
2015 $511
2014 $N/A
2013 $171
2012 $166
2011 $126
Sector Industry Market Cap Revenue
Medical MED-DRUGS $4.827B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $95.374B 35.78
Zoetis (ZTS) US $69.448B 26.29
Daiichi Sankyo, - (DSNKY) JP $48.414B 24.63
Takeda Pharmaceutical (TAK) JP $47.824B 10.59
Sandoz Group AG (SDZNY) CH $18.977B 0.00
Summit Therapeutics (SMMT) US $18.321B 0.00
Merck (MKKGY) DE $17.848B 14.77
Shionogi (SGIOY) JP $14.096B 14.12
United Therapeutics (UTHR) US $13.255B 11.73
Neurocrine Biosciences (NBIX) US $10.546B 32.40
IPSEN (IPSEY) FR $9.907B 0.00
Orion OYJ (ORINY) FI $9.027B 24.41
Corcept Therapeutics (CORT) US $7.580B 57.65
Madrigal Pharmaceuticals (MDGL) US $7.276B 0.00
Stevanato Group S.p.A (STVN) IT $6.281B 39.88
Ono Pharmaceutical (OPHLF) JP $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) GB $5.813B 0.00
Ionis Pharmaceuticals (IONS) US $5.047B 0.00
Soleno Therapeutics (SLNO) US $3.744B 0.00
Crinetics Pharmaceuticals (CRNX) US $3.138B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.960B 12.02
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.399B 14.89
Hypermarcas (HYPMY) BR $2.350B 15.46
Recursion Pharmaceuticals (RXRX) US $2.211B 0.00
NewAmsterdam Pharma (NAMS) NL $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.822B 0.00
Centessa Pharmaceuticals (CNTA) GB $1.798B 0.00
Indivior (INDV) US $1.593B 6.75
Guardian Pharmacy Services (GRDN) US $1.568B 0.00
Evotec AG (EVO) DE $1.502B 0.00
ARS Pharmaceuticals (SPRY) US $1.391B 177.00
Dyne Therapeutics (DYN) US $1.362B 0.00
Ocular Therapeutix (OCUL) US $1.359B 0.00
Ardelyx (ARDX) US $1.304B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.121B 45.56
Enliven Therapeutics (ELVN) US $0.974B 0.00
Harrow (HROW) US $0.917B 0.00
Collegium Pharmaceutical (COLL) US $0.869B 4.62
Avadel Pharmaceuticals (AVDL) IE $0.832B 0.00
Xencor (XNCR) US $0.773B 0.00
Cronos Group (CRON) CA $0.721B 0.00
AleAnna (ANNA) US $0.718B 0.00
Xeris Biopharma Holdings (XERS) US $0.701B 0.00
KalVista Pharmaceuticals (KALV) US $0.676B 0.00
Organogenesis (ORGO) US $0.629B 0.00
Akebia Therapeutics (AKBA) US $0.626B 0.00
Bioventus (BVS) US $0.595B 15.45
Savara (SVRA) US $0.563B 0.00
Relay Therapeutics (RLAY) US $0.561B 0.00
USANA Health Sciences (USNA) US $0.529B 11.35
Regulus Therapeutics (RGLS) US $0.520B 0.00
Theravance Biopharma (TBPH) KY $0.520B 0.00
Verve Therapeutics (VERV) US $0.490B 0.00
Tourmaline Bio (TRML) US $0.458B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.458B 0.00
Elite Pharmaceuticals (ELTP) US $0.454B 0.00
Zevra Therapeutics (ZVRA) US $0.418B 0.00
Altimmune (ALT) US $0.398B 0.00
Siga Technologies (SIGA) US $0.388B 6.62
Oruka Therapeutics (ORKA) US $0.378B 0.00
CytoDyn (CYDY) US $0.368B 0.00
Heron Therapeutics (HRTX) US $0.358B 0.00
Rigel Pharmaceuticals (RIGL) US $0.334B 19.92
Aquestive Therapeutics (AQST) US $0.298B 0.00
ProKidney (PROK) US $0.250B 0.00
Avita Medical (RCEL) US $0.247B 0.00
Nature's Sunshine Products (NATR) US $0.227B 26.70
Wellgistics Health (WGRX) US $0.223B 0.00
OmniAb (OABI) US $0.216B 0.00
Esperion Therapeutics (ESPR) US $0.195B 24.60
MediWound (MDWD) IL $0.186B 0.00
Larimar Therapeutics (LRMR) US $0.183B 0.00
Korro Bio (KRRO) US $0.173B 0.00
Inhibikase Therapeutics (IKT) US $0.167B 0.00
Aldeyra Therapeutics (ALDX) US $0.162B 0.00
4D Molecular Therapeutics (FDMT) US $0.159B 0.00
Journey Medical (DERM) US $0.159B 0.00
Lexeo Therapeutics (LXEO) US $0.156B 0.00
Nanobiotix S.A (NBTX) FR $0.156B 0.00
Procaps Group, S.A (PROCF) LU $0.156B 0.00
Aclaris Therapeutics (ACRS) US $0.149B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.148B 45.60
Nektar Therapeutics (NKTR) US $0.145B 0.00
Profound Medical (PROF) CA $0.145B 0.00
Lyell Immunopharma (LYEL) US $0.139B 0.00
Protara Therapeutics (TARA) US $0.133B 0.00
Enanta Pharmaceuticals (ENTA) US $0.129B 0.00
Innate Pharma SA (IPHYF) FR $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.116B 0.00
VAXART, INC (VXRT) US $0.098B 0.00
OptiNose (OPTN) US $0.095B 0.00
Cardiol Therapeutics (CRDL) CA $0.093B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.092B 0.00
Champions Oncology (CSBR) US $0.088B 14.50
Achieve Life Sciences (ACHV) CA $0.085B 0.00
Arch Biopartners (ACHFF) CA $0.083B 0.00
Galectin Therapeutics (GALT) US $0.082B 0.00
ESSA Pharma (EPIX) CA $0.079B 0.00
Cassava Sciences (SAVA) US $0.078B 0.00
Unicycive Therapeutics (UNCY) US $0.078B 0.00
Context Therapeutics (CNTX) US $0.077B 0.00
Telomir Pharmaceuticals (TELO) US $0.075B 0.00
Dominari Holdings (DOMH) US $0.075B 0.00
Nutriband (NTRB) US $0.070B 0.00
Pyxis Oncology (PYXS) US $0.068B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.067B 0.00
Inotiv (NOTV) US $0.067B 0.00
Gain Therapeutics (GANX) US $0.064B 0.00
Assertio Holdings (ASRT) US $0.062B 0.00
Fractyl Health (GUTS) US $0.062B 0.00
Vivani Medical (VANI) US $0.062B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Karyopharm Therapeutics (KPTI) US $0.058B 0.00
Metagenomi (MGX) US $0.056B 0.00
ElectroCore (ECOR) US $0.054B 0.00
Avalo Therapeutics (AVTX) US $0.054B 0.00
PMV Pharmaceuticals (PMVP) US $0.052B 0.00
Century Therapeutics (IPSC) US $0.048B 0.00
Mural Oncology (MURA) IE $0.045B 0.00
Verrica Pharmaceuticals (VRCA) US $0.043B 0.00
Acrivon Therapeutics (ACRV) US $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.041B 0.00
Prelude Therapeutics (PRLD) US $0.040B 0.00
Rafael Holdings (RFL) US $0.040B 0.00
Iterum Therapeutics (ITRM) IE $0.039B 0.00
SCYNEXIS (SCYX) US $0.038B 0.00
NRx Pharmaceuticals (NRXP) US $0.036B 0.00
Surrozen (SRZN) US $0.034B 0.00
FibroGen (FGEN) US $0.034B 0.00
PolyPid (PYPD) IL $0.029B 0.00
Tempest Therapeutics (TPST) US $0.025B 0.00
CASI Pharmaceuticals (CASI) CN $0.024B 0.00
Enlivex Therapeutics (ENLV) IL $0.022B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
VYNE Therapeutics (VYNE) US $0.020B 0.00
Mannatech (MTEX) US $0.020B 7.86
Lipocine (LPCN) US $0.019B 0.00
Natural Alternatives (NAII) US $0.019B 0.00
DURECT (DRRX) US $0.018B 0.00
GlycoMimetics (GLYC) US $0.017B 0.00
TherapeuticsMD (TXMD) US $0.016B 0.00
Vivos Therapeutics (VVOS) US $0.016B 0.00
BioVie (BIVI) US $0.016B 0.00
MEI Pharma (MEIP) US $0.014B 0.00
ProPhase Labs (PRPH) US $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.013B 0.00
TransCode Therapeutics (RNAZ) US $0.013B 0.00
Cosmos Health (COSM) US $0.013B 0.00
Scienture Holdings (SCNX) US $0.012B 0.00
Minerva Neurosciences (NERV) US $0.012B 8.79
Relmada Therapeutics (RLMD) US $0.012B 0.00
BioLineRx (BLRX) IL $0.011B 0.00
Plus Therapeutics (PSTV) US $0.011B 0.00
Ernexa Therapeutics (ERNA) US $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.010B 3.16
Biomerica (BMRA) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Phio Pharmaceuticals (PHIO) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Carisma Therapeutics (CARM) US $0.008B 0.00
Ainos (AIMD) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Mangoceuticals (MGRX) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Jaguar Animal Health (JAGX) US $0.008B 0.00
Indaptus Therapeutics (INDP) US $0.008B 0.00
Traws Pharma (TRAW) US $0.008B 0.00
Lyra Therapeutics (LYRA) US $0.007B 0.00
Citius Pharmaceuticals (CTXR) US $0.007B 0.00
Conduit Pharmaceuticals (CDT) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
NLS Pharmaceutics (NLSP) CH $0.005B 0.00
Klotho Neurosciences (KLTO) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
CERo Therapeutics Holdings (CERO) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Xenetic Biosciences (XBIO) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
Redhill Biopharma (RDHL) IL $0.004B 0.00
InMed Pharmaceuticals (INM) CA $0.004B 0.00
Alaunos Therapeutics (TCRT) US $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Qualigen Therapeutics (QLGN) US $0.003B 0.00
Incannex Healthcare (IXHL) AU $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
PainReform (PRFX) IL $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.002B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Heatwurx (PCSA) US $0.001B 0.00
Petros Pharmaceuticals (PTPI) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Aditxt (ADTX) US $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00